Another strategy for improving efficacy can be combinational therapy of EV-T with other therapeutic agents, which can regulate the modulator expression levels in TRAIL signaling pathway and thus sensitizes TRAIL response in cancer cells [2]. Here, TNFSF10 is linked to cancer.